Emerging studies found that the levels of DNMT1, DNMT3A, and DNMT3B mRNA are reportedly increased in various malignancies, including colorectal, liver, and gastric cancers (Eads et al, 1999; Oh et al, 2007; Ding et al, 2008). This evidence concerns the gene DNMT3B and gastric cancer.